Anzeige
Mehr »
Sonntag, 22.02.2026 - Börsentäglich über 12.000 News
Hammermeldung: Der Startschuss für die nächste Drohnen-Generation ist gefallen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
173 Leser
Artikel bewerten:
(0)

Gleneagles Global Health City (GGHC): An Omani Teacher Gets a Fresh Lease of Life at Gleneagles Global Health City After his Fourth Open Heart Surgery

- Doctors at Gleneagles Global Health City perform a high-risk cardiac surgery on a patient with repeated heart valve infection using a human heart valve

CHENNAI, India, Oct. 20, 2021 /PRNewswire/ -- Gleneagles Global Health City (GGHC), a leading multi-speciality centre in Chennai, successfully replaced an infected heart valve of a 39 year old patient, from Oman, with a homograft aortic heart valve from brain dead patients.

Doctors at Gleneagles Global Health City perform a high-risk cardiac surgery on a patient with repeated heart valve infection using a human heart valve

Mr. Hilal, an Arabic teacher from Oman, underwent 3 complicated heart surgeries to clear the infection in his heart valve that were identified due to an unexplained fever and a dental procedure. Despite these surgeries, he developed recurrent infection around the mechanical valve inside his heart. As an additional complication, he developed ballooning of his aorta due to infection which is known as pseudo aneurysm of the aorta.

While facing these complications, Mr. Hilal was referred to GGHC for treatment of the heart valve infection. The multi-disciplinary team of doctors evaluated his condition to understand the best possible treatment for the patient. In view of repeated infection of the mechanical heart valve, which is made of metal and covered with fabric, the team decided to replace his infected heart valve with a homograft aortic valve. A homograft is an aortic or pulmonic valve that has been removed from a donated human heart, preserved, antibiotic-treated, and frozen under sterile conditions. This homograft aortic valve is derived from hearts donated by brain dead patients that are harvested and stored at -70 degrees in liquid nitrogen.

In the first week of September, Mr. Hilal underwent a complex and meticulously planned heart surgery for the 4th time. The procedure involved cooling down the patient's body down to 18°C to allow pausing of his blood circulation for 8 minutes to open and control his pseudo aortic aneurysm. During this period, where there was no blood flow to his body, his brain was perfused blood by a special tube placed in the carotid artery (selective antegrade cerebral perfusion). The previously infected heart valve was removed and the infection surrounding it was thoroughly cleaned. A new aortic valve (Cryopreserved homograft) was implanted in the centre of the aorta.

Dr. R. Anto Sahayaraj, Senior Consultant - Cardiothoracic and Vascular Surgery, Gleneagles Global Health City, Chennai, said, "Upon arrival, the patient showed severe infection in his heart valve and was taken into emergency. The main challenge was to get to the centre of the patient's heart in a setting of a densely scarred chest, due to previous performed multiple cardiac surgeries and with a pseudo aneurysm ready to burst, sitting right under the breast bone. This warranted a detailed discussion in arriving at a safe and comprehensive treatment strategy."

Dr. Subramanian Swaminathan, Director - Infectious Diseases, Gleneagles Global Health City, Chennai, said, "The recurrent heart valve infection did not respond well to conventional treatment. At GGHC, we had designed a new regimen which is more potent when combined with surgery. During the procedure, the patient was under close monitoring of our team."

Dr. Susan George, Senior Consultant - Cardiology, Gleneagles Global Health City, Chennai, said, "Upon evaluation by echocardiogram, the patient was found to have a severe leak of blood from the aorta into the left ventricle by the side of the mechanical prosthetic valve medically known as paravalvar leak and an abscess cavity secondary to the infection of the valve. There was also a false aneurysm of the ascending aorta which made the situation extremely challenging to perform a surgery. With the patient having undergone 3 surgeries in the past, it was extremely crucial for us to ensure that the patient was safe from any further risk of infection."

The patient recovered and flew black home after 2 weeks of post-operative care with a wide smile and heart full of gratitude, only to get back to teaching Arabic.

Praising the team on the accomplishment of the case, Dr. Alok Khullar, CEO, Gleneagles Global Health City, Chennai said, "We are truly happy with the outcome of this complex procedure. It is a commendable effort taken by our team of experts to ensure that quality care and specialized treatment is provided to extremely challenging cases as well."

Photo: https://mma.prnewswire.com/media/1665175/GGHC.jpg

© 2021 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.